KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EBITDA (2016 - 2025)

Historic EBITDA for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $2.9 billion.

  • Merck's EBITDA rose 2880000.0% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 billion, marking a year-over-year increase of 55973.03%. This contributed to the annual value of $4.7 billion for FY2024, which is 13331.46% up from last year.
  • Merck's EBITDA amounted to $2.9 billion in Q3 2025, which was up 2880000.0% from $1.4 billion recorded in Q2 2025.
  • Merck's EBITDA's 5-year high stood at $2.9 billion during Q3 2025, with a 5-year trough of -$9.4 billion in Q2 2023.
  • For the 5-year period, Merck's EBITDA averaged around -$178.6 million, with its median value being $35.0 million (2021).
  • Per our database at Business Quant, Merck's EBITDA plummeted by 2301666.67% in 2021 and then surged by 2880000.0% in 2025.
  • Quarter analysis of 5 years shows Merck's EBITDA stood at $35.0 million in 2021, then plummeted by 1151.43% to -$368.0 million in 2022, then crashed by 1519.02% to -$6.0 billion in 2023, then skyrocketed by 105.74% to $342.0 million in 2024, then surged by 745.03% to $2.9 billion in 2025.
  • Its EBITDA stands at $2.9 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $2.5 billion for Q1 2025.